- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 8 - Immunotherapy and Pathways: Safety Considerations
In this segment, experts Peter Salgo, MD; Ira M. Klein, MD, MBA, FACP; Bryan Loy, MD; and Irwin W. Tischler, DO, discuss immunotherapy options and their potential in the treatment of many types of cancer. The panelists also consider how to evaluate the safety of a treatment when used as part of a pathway.
Although targeted agents and immunotherapies have not yet been incorporated into pathways, the use of these agents is reimbursed when used in appropriate patients, notes Dr Tischler. Dr Klein adds that an important part of using pathways is gathering data from providers on treatment choices that are outside of a pathway. These data should be collected and providers should be given feedback on their nonadherence to pathways, to help drive value.
Dr Salgo adds that when measuring value, safety is an important consideration. Dr Klein explains that safety is a key reason for the establishment of pathways, which are designed to help put “guardrails” on the use of evidence-based medicine.
Dr Loy adds that when reviewing the safety of immunotherapeutic options, or oncology drugs in general, it is important to consider the treatment plan as a whole, including use of support drugs (eg, antiemetics). The total cost of care should be considered, including data on avoidable consequences, such as visits to the emergency department.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
AUA to Focus on Inclusive Care, Robotic Surgeries, and Future of Urology at 2024 Annual Meeting
May 1st 2024The American Urological Association (AUA) 2024 Annual Meeting will highlight the latest innovations and future trends in urology, featuring dynamic plenary sessions, educational opportunities for providers, and discussions on cutting-edge treatments and global health initiatives.
Read More
